Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Boost Your Portfolio With These 5 Low Price-to-Book Stocks
10:10am, Wednesday, 30'th Apr 2025
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, MD, PFE, STNE and SAN are some such stocks.
Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul
07:05am, Wednesday, 30'th Apr 2025
Entering trading on Monday, the S&P 500 has declined around 6% since the start of the year. And that's after recovering recently -- it was down much more than that in early April when global tariffs w
Pfizer's Dividend Yield Is 7.5%. Is It Still Safe?
06:15am, Wednesday, 30'th Apr 2025
When a stock yields more than 5%, investors start to become skeptical about whether the payout is indeed safe. While it's tempting to want to believe that it can be safe and that it can be an excellen
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
04:51am, Wednesday, 30'th Apr 2025
The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their weight
Pfizer's Q1 Update May Mark A Bottom In The Stock
04:24am, Wednesday, 30'th Apr 2025
Pfizer is facing some revenue pressures due to some higher Medicare discounts, and this has led to a small miss on revenue delivery in Q1 FY25. Pfizer is making meaningful improvements on profitabili
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain
03:15am, Wednesday, 30'th Apr 2025
Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth treatment areas: and that's weight loss. Analysts forecast a compound annual g
Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away
12:30am, Wednesday, 30'th Apr 2025
Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US.
Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?
09:35pm, Tuesday, 29'th Apr 2025
Pfizer (PFE) shares spiked 3% in Tuesday's trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations.
Pfizer Inc. (PFE) Q1 2025 Earnings Call Transcript
03:47pm, Tuesday, 29'th Apr 2025
Pfizer Inc. (NYSE:PFE ) Q1 2025 Results Conference Call April 29, 2024 10:00 AM ET Company Participants Francesca DeMartino - Chief Investment Relations Officer and Senior Vice President Dr. Albert Bo
Pfizer's 7% Yield Makes It Look Like a Junk Bond—But Better
02:11pm, Tuesday, 29'th Apr 2025
The big decline in Pfizer's share price may have a silver lining.
Stocks on the move: Pfizer and Uber
01:30pm, Tuesday, 29'th Apr 2025
Pfizer's down after earnings — and Josh Brown, CEO of Ritholtz Wealth Management, is making moves. Hear why he's trimming Pfizer and what he sees in Uber!
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
01:13pm, Tuesday, 29'th Apr 2025
It comes as drugmakers brace for Trump's levies on pharmaceuticals imported into the U.S. – his administration's bid to boost manufacturing in the country.
Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales
12:35pm, Tuesday, 29'th Apr 2025
PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.
Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings
12:10pm, Tuesday, 29'th Apr 2025
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 250 points on Tuesday.
Breaking down Pfizer's first quarter earnings results, tariff impacts
11:39am, Tuesday, 29'th Apr 2025
Pfizer's (PFE) first quarter earnings were mixed, with sales coming in narrowly below Wall Street expectations. The pharmaceutical company has reaffirmed its 2025 outlook and announced plans for $1.2
